Home
Scholarly Works
The Effect of Rivaroxaban Exposure and Clinical...
Conference

The Effect of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients with Nonvalvular Atrial Fibrillation

Authors

Yan X; Peters G; Sharma A; Nandy P; Nessel C; Garmann D; Willmann S; Hermanowski-Vosatka A; Solms A; Berkowitz SD

Volume

130

Publisher

AMER SOC HEMATOLOGY

Publication Date

December 7, 2017

Name of conference

59th Annual Meeting of the American-Society-of-Hematology (ASH)

Conference place

Atlanta, GA

Conference start date

December 9, 2017

Conference end date

December 12, 2017

Conference proceedings

BLOOD

ISSN

0006-4971

Contact the Experts team